| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/16/2010 | CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 03/16/2010 | CA2372575C Bradykinin receptor antagonists |
| 03/11/2010 | WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 03/11/2010 | US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 03/11/2010 | US20100063040 Sulfonamide Derivative Having PGD2 Receptor Antagonistic Activity |
| 03/11/2010 | US20100063036 Substituted morpholine and thiomorpholine derivatives |
| 03/11/2010 | US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders |
| 03/11/2010 | US20100062055 Lipid-based nitric oxide donors |
| 03/11/2010 | CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors |
| 03/10/2010 | CN101665473A Substituted benzene propenyl piperazinyl alkyl polyhydric benzamide compound and preparation method and application thereof |
| 03/09/2010 | US7674899 Dimeric azacyclic compounds and their use |
| 03/09/2010 | US7674825 Cardiovascular disorders; stimulant of guanylate cyclase |
| 03/09/2010 | US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/04/2010 | WO2010024298A1 Potassium channel regulator |
| 03/04/2010 | WO2010023687A2 Preparation of ranolazine, its salts and intermediates thereof |
| 03/04/2010 | WO2010023446A1 Novel potassium channel blockers |
| 03/04/2010 | WO2010023445A1 Novel potassium channel blocker |
| 03/04/2010 | US20100056780 Novel o-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease |
| 03/04/2010 | US20100056545 Novel phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of t-type calcium ion channel containing the same as an active ingredient |
| 03/04/2010 | US20100056528 Sulfonamide derivatives with therapeutic indications |
| 03/04/2010 | CA2735158A1 Compositions and methods of treating amyloid disease |
| 03/03/2010 | EP2159221A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/03/2010 | EP2158189A1 Cyclohexyl derivatives |
| 03/03/2010 | EP2079717B1 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia, and water by means of distillation |
| 03/03/2010 | EP1773796B1 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 03/03/2010 | EP1487790B1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | CN101659646A Cinepazide maleate crystal forms and preparation method thereof |
| 03/03/2010 | CN101659645A Method for preparing 3-fluorine-4 morpholinyl phenylamine |
| 03/03/2010 | CN101659644A Method for synthesizing 2-methyl-1-[4-(methylthio)phenyl]-2-(4-morpholinyl)-1-propanon |
| 03/02/2010 | US7671198 Process for preparing intermediates to 5-HT4 receptor agonist compounds |
| 03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
| 03/02/2010 | US7671058 N-(3,4-disubstituted phenyl) salicylamide derivatives |
| 03/02/2010 | US7671053 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide for treatment of asthma and COPD; purinergic receptors (P2X7) |
| 03/02/2010 | US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 02/25/2010 | WO2010020548A1 Glyt1 receptor antagonists |
| 02/25/2010 | WO2009152356A3 Compounds and compositions useful for the treatment of malaria |
| 02/25/2010 | WO2009133179A3 Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters |
| 02/25/2010 | WO2009132740A3 Reactive ionic liquids |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048890 Conjugated small molecules |
| 02/25/2010 | US20100048651 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048550 Selective tr-beta 1 agonist |
| 02/25/2010 | US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| 02/25/2010 | CA2730478A1 Prodrugs of methyl hydrogen fumarate |
| 02/24/2010 | EP2155736A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 02/24/2010 | EP2155707A1 Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| 02/24/2010 | EP2155706A2 Repaglinide substantially free of dimer impurity |
| 02/24/2010 | EP2155697A1 Substituted piperazines |
| 02/24/2010 | EP2155663A1 Substituted 2- ý2- (phenyl) ethylamino¨alkaneamide derivatives and their use as sodium and/or calcium channel modulators |
| 02/24/2010 | EP2155659A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 02/24/2010 | EP2155643A1 Ire-1a inhibitors |
| 02/24/2010 | EP2155198A2 Piperidine/piperazine derivatives |
| 02/24/2010 | EP1658066B9 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/24/2010 | EP1458675B1 Alpha-cyanoacrylates |
| 02/24/2010 | CN101657437A New procedure for preparation of levocetirizine and its intermediates |
| 02/23/2010 | US7667044 treating nervous system diorders such as Alzheimer's disease, Down Syndrome, Parkinson disease and Huntington chorea by administering inhibitors of prolyl endopeptidases |
| 02/23/2010 | US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation |
| 02/23/2010 | US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative |
| 02/23/2010 | US7666865 Calcium channel blockers |
| 02/23/2010 | CA2446890C Deuterated 3-piperidinopropiophenones and pharmaceutical drugs containing these compounds |
| 02/23/2010 | CA2345146C Cyanophenyl derivative |
| 02/23/2010 | CA2335461C Calcium channel blockers |
| 02/23/2010 | CA2329930C Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/18/2010 | WO2010017850A1 Process for preparing cycloalkyl-substituted piperazine compounds |
| 02/18/2010 | US20100041657 Haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100041573 Amine reaction compounds comprising one or more active ingredient |
| 02/18/2010 | US20100038578 Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device |
| 02/18/2010 | CA2735560A1 Process for preparing cycloalkyl-substituted piperazine compounds |
| 02/17/2010 | EP2152663A2 Tri-aryl compounds and compositions comprising the same |
| 02/17/2010 | EP2152270A1 Piperidine/piperazine derivatives |
| 02/17/2010 | EP2152269A1 Piperidine/piperazine derivatives |
| 02/17/2010 | EP2152256A2 Telomerase activating compounds and methods of use thereof |
| 02/17/2010 | EP1487810B1 4-(diarylmethyl)-1-piperazinyl derivatives |
| 02/17/2010 | EP1420775B1 Platinum complexes and their uses in therapy |
| 02/16/2010 | US7662750 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
| 02/11/2010 | WO2010017060A1 Urea derivatives as antibacterial agents |
| 02/11/2010 | WO2010016554A1 Cyclic amine compound |
| 02/11/2010 | WO2009154754A3 Synthesis of deuterated morpholine derivatives |
| 02/11/2010 | US20100036119 Fluorinating reagents and their preparation |
| 02/11/2010 | US20100036084 Biodegradable poly(beta-amino esters) and uses thereof |
| 02/11/2010 | US20100035879 N-sulfonylcarboximidamide apoptosis promoters |
| 02/11/2010 | CA2732045A1 Urea derivatives as antibacterial agents |
| 02/10/2010 | EP2150550A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 02/10/2010 | EP2150540A2 Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions containing the same, and agent formulations containing tolperisone |
| 02/10/2010 | EP2150530A1 Substituted sulfonamide derivatives |
| 02/10/2010 | EP2150527A2 Anthranilic acid derivative as anticancer agent and a process for the preparation thereof |
| 02/10/2010 | EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/09/2010 | US7659400 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 02/09/2010 | US7659396 N-(2,4,6-triisopropylphenylsulfonyl)-3-amidino(or guanidino)phenyl-alanine 4-ethoxycarbonylpiperazide; urokinase inhibitors; reacting a 3-cyanophenylalanine with a quaternary ammonium hydroxide and reacting the product with a phenylsulfonyl halide; industrial scale; simplification; cost efficiency |
| 02/09/2010 | US7659395 Analgesics; antidiabetic agents;anticancer agents;psychological disorders; schizophrenia; neurodegenerative diseases |